{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:40:23Z","timestamp":1793176823875,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clgc.2023.09.008","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T18:04:32Z","timestamp":1696183472000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and Prognostic Value of Neutrophil-Lymphocyte Ratio in Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-610X","authenticated-orcid":false,"given":"Chengquan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanzong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2023.09.008_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clgc.2023.09.008_bib0002","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1210\/jc.2010-0990","article-title":"Approach to the patient with adrenocortical carcinoma","volume":"95","author":"Lacroix","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clgc.2023.09.008_bib0003","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2010-0457","article-title":"Approach to the patient with an adrenal incidentaloma","volume":"95","author":"Nieman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clgc.2023.09.008_bib0004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1677\/ERC-07-0045","article-title":"The optimal imaging of adrenal tumours: a comparison of different methods","volume":"14","author":"Ilias","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clgc.2023.09.008_bib0005","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00268-011-1374-2","article-title":"Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors","volume":"36","author":"Gust","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.clgc.2023.09.008_bib0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-10-0666","article-title":"Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy","volume":"164","author":"Leboulleux","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0007","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clgc.2023.09.008_bib0008","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/curroncol28010025","article-title":"Genomic and clinical correlates of adrenocortical carcinoma in an adult patient with Li-Fraumeni Syndrome: a case report","volume":"28","author":"Bondy","year":"2020","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0009","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2023.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2023.09.008_bib0011","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","article-title":"Neutrophils as active regulators of the immune system in the tumor microenvironment","volume":"102","author":"Shaul","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2567.2008.02950.x","article-title":"Neutrophil mobilization and clearance in the bone marrow","volume":"125","author":"Furze","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.clgc.2023.09.008_bib0013","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.MP.0000020391.98998.6B","article-title":"Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy","volume":"15","author":"Caruso","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0014","first-page":"483","article-title":"Human neutrophil-mediated cytotoxicity to tumor cells","volume":"66","author":"Gerrard","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2023.09.008_bib0015","first-page":"175","article-title":"The role of neutrophils as cytotoxic cells in lung metastasis: suppression of tumor cell metastasis by a biological response modifier (PSK)","volume":"12","author":"Ishihara","year":"1998","journal-title":"In Vivo (Brooklyn)"},{"key":"10.1016\/j.clgc.2023.09.008_bib0016","doi-asserted-by":"crossref","DOI":"10.4161\/15384101.2014.950163","article-title":"Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells","volume":"3","author":"Yan","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clgc.2023.09.008_bib0017","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00281-012-0344-6","article-title":"Protumor and antitumor functions of neutrophil granulocytes","volume":"35","author":"Brandau","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12894-017-0240-4","article-title":"The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis","volume":"17","author":"Mochizuki","year":"2017","journal-title":"BMC Urol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0019","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00268-020-05868-6","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as possible prognostic markers for patients undergoing resection of adrenocortical carcinoma","volume":"45","author":"de Jong","year":"2021","journal-title":"World J Surg"},{"key":"10.1016\/j.clgc.2023.09.008_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/07435800.2020.1870234","article-title":"Neutrophil-lymphocyte ratio as a prognostic marker in adrenocortical carcinoma","volume":"46","author":"Solak","year":"2021","journal-title":"Endocr Res"},{"key":"10.1016\/j.clgc.2023.09.008_bib0021","first-page":"439","article-title":"May hemocytometer parameters be a biomarker in distinguishing between adrenal adenomas and carcinomas and in prognosis of adrenocortical carcinomas?","volume":"59","author":"Sisman","year":"2020","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.clgc.2023.09.008_bib0022","first-page":"286","article-title":"Neutralizing tumor-promoting chronic inflammation: a magic bullet?","volume":"339","author":"Coussens","year":"2013","journal-title":"Science (1979)"},{"key":"10.1016\/j.clgc.2023.09.008_bib0023","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0163-7258(94)90023-X","article-title":"Coley's toxins, tumor necrosis factor and cancer research: a historical perspective","volume":"64","author":"Wiemann","year":"1994","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clgc.2023.09.008_bib0024","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2023.09.008_bib0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clgc.2023.09.008_bib0026","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40618-013-0049-2","article-title":"Management of adrenal cancer: a 2013 update","volume":"37","author":"Terzolo","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clgc.2023.09.008_bib0027","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/ERC-15-0452","article-title":"Future directions in the diagnosis and medical treatment of adrenocortical carcinoma","volume":"23","author":"Creemers","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clgc.2023.09.008_bib0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2023.09.008_bib0029","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/jso.25760","article-title":"Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma","volume":"120","author":"Gaitanidis","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clgc.2023.09.008_bib0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jso.23982","article-title":"Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma","volume":"112","author":"Bagante","year":"2015","journal-title":"J Surg Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:30:18Z","timestamp":1793176218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1558767323002185"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.09.008","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic and Prognostic Value of Neutrophil-Lymphocyte Ratio in Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}